However, as BRCA1 and BRCA2 cancers comprise only 5 to 10% of all cancers and potential controls were excluded if a family history of breast or ovarian cancer was noted in the medical record, it seems very unlikely that more than a few of the 'control' cases had germline BRCA1 mutations. The gene discussed is BRCA2; the disease is ovarian cancer.